203 related articles for article (PubMed ID: 36443011)
1. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
Ferreira D; Przybelski SA; Lesnick TG; Schwarz CG; Diaz-Galvan P; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Jones DT; Savica R; Ferman TJ; Graff-Radford N; Lowe VJ; Jack CR; Petersen RC; Westman E; Boeve BF; Kantarci K
Neurology; 2023 Feb; 100(8):e846-e859. PubMed ID: 36443011
[TBL] [Abstract][Full Text] [Related]
2. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
[TBL] [Abstract][Full Text] [Related]
3. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
Diaz-Galvan P; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Min HP; Jain M; Miyagawa T; Forsberg LK; Fields JA; Savica R; Graff-Radford J; Jones DT; Botha H; St Louis EK; Knopman DS; Ramanan VK; Ross O; Graff-Radford N; Day GS; Dickson DW; Ferman TJ; Petersen RC; Lowe VJ; Boeve BF; Kantarci K
Neurology; 2023 Jul; 101(2):e178-e188. PubMed ID: 37202168
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies.
Chen Q; Przybelski SA; Senjem ML; Schwarz CG; Lesnick TG; Botha H; Knopman DS; Graff-Radford J; Savica R; Jones DT; Fields JA; Jain MK; Graff-Radford NR; Ferman TJ; Kremers WK; Jack CR; Petersen RC; Boeve BF; Lowe VJ; Kantarci K
Mov Disord; 2022 Jun; 37(6):1256-1264. PubMed ID: 35261094
[TBL] [Abstract][Full Text] [Related]
6. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies.
Abdelnour C; Ferreira D; Oppedal K; Cavallin L; Bousiges O; Wahlund LO; Hort J; Nedelska Z; Padovani A; Pilotto A; Bonanni L; Kramberger MG; Boada M; Westman E; Pagonabarraga J; Kulisevsky J; Blanc F; Aarsland D
Neuroimage Clin; 2020; 27():102333. PubMed ID: 32674011
[TBL] [Abstract][Full Text] [Related]
7. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.
Wolters EE; van de Beek M; Ossenkoppele R; Golla SSV; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Barkhof F; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lemstra AW; van Berckel BNM
Neuroimage Clin; 2020; 28():102504. PubMed ID: 33395993
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
[TBL] [Abstract][Full Text] [Related]
9. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
[TBL] [Abstract][Full Text] [Related]
10. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
[TBL] [Abstract][Full Text] [Related]
11. Performance of a [
Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
Neurology; 2023 Nov; 101(19):e1850-e1862. PubMed ID: 37748892
[TBL] [Abstract][Full Text] [Related]
12. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
[TBL] [Abstract][Full Text] [Related]
13. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
[TBL] [Abstract][Full Text] [Related]
14. Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer's disease.
de Oliveira FF; Miraldo MC; de Castro-Neto EF; de Almeida SS; Matas SLA; Bertolucci PHF; Naffah-Mazzacoratti MDG
Aging Clin Exp Res; 2023 Aug; 35(8):1741-1752. PubMed ID: 37264166
[TBL] [Abstract][Full Text] [Related]
15. β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.
Ferreira D; Przybelski SA; Lesnick TG; Lemstra AW; Londos E; Blanc F; Nedelska Z; Schwarz CG; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Savica R; Ferman TJ; Graff-Radford NR; Lowe VJ; Jack CR; Petersen RC; Mollenhauer B; Garcia-Ptacek S; Abdelnour C; Hort J; Bonanni L; Oppedal K; Kramberger MG; Boeve BF; Aarsland D; Westman E; Kantarci K
Neurology; 2020 Dec; 95(24):e3257-e3268. PubMed ID: 32989106
[TBL] [Abstract][Full Text] [Related]
16. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
[TBL] [Abstract][Full Text] [Related]
17. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
19. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
[TBL] [Abstract][Full Text] [Related]
20. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
